Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial

Caren Sourij, Abderrahim Oulhaj, Faisal Aziz, Norbert J. Tripolt, Felix Aberer, Peter N. Pferschy, Marek Postula, H. Drexel, Martin Benedikt, Ewald Kolesnik, Thomas R. Pieber, Heiko Bugger, Dirk von Lewinski, Harald Sourij

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalDiabetes, Obesity and Metabolism
DOIs
Publication statusAccepted/In press - 2024
Externally publishedYes

Keywords

  • N-terminal prohormone of brain natriuretic peptide
  • empagliflozin
  • myocardial infarction
  • prediabetes
  • sodium-glucose cotransporter 2 inhibitors
  • type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this